Non-Small Cell Lung Cancer

N/A

Published by: @Point of Care
Downloads
Revenue

Description

@Point of Care™ With @sk Cognitive is a clinical decision-making mobile platform. Non-Small Cell Lung Cancer @Point of Care™ provides a streamlined clinical decision support tool for clinicians to obtain content when it is needed—enabling better decisions, better outcomes, and better care.
With @sk Cognitive AI, clinicians use @Point of Care™ to easily access curated, evidence-based, and disease-specific medical content. Clinicians navigate content by asking voice-enabled natural language questions. With Watson, confidence-rated answers to efficiently incorporate best treatment options happen more quickly and decisions are made faster to improve patient outcomes at the point of care.
Non-Small Cell Lung Cancer @Point of Care™ is designed to:
• Support discovery and practice change
• Provide relevant, evidence-based disease-specific medical content
• Improve patient outcomes at the point of care
Features:
• Continually updated Non-Small Cell Lung Cancer content
• Topics in diagnosis, treatment, and care management developed with expert physician authors
• Case studies, videos, and interviews
• Access to actionable patient-recorded data
• Detailed reference list with access to original sources
• Continuing medical education credit (CME/CE)
• Surveys and peer polling
• Patient education resources to share with patients
• BreakingMED™ news feed
Hide Show More...

Screenshots

Non-Small Cell Lung Cancer FAQ

  • Is Non-Small Cell Lung Cancer free?

    Yes, Non-Small Cell Lung Cancer is completely free and it doesn't have any in-app purchases or subscriptions.

  • Is Non-Small Cell Lung Cancer legit?

    Not enough reviews to make a reliable assessment. The app needs more user feedback.

    Thanks for the vote

  • How much does Non-Small Cell Lung Cancer cost?

    Non-Small Cell Lung Cancer is free.

  • What is Non-Small Cell Lung Cancer revenue?

    To get estimated revenue of Non-Small Cell Lung Cancer app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.

User Rating
App is not rated in Chile yet.
Ratings History

Non-Small Cell Lung Cancer Reviews

X

tsjbrmcrblgngtb on

United States

Very helpful. Thanks.

Store Rankings

Ranking History
Category Rankings
App is not ranked yet

Keywords

Non-Small Cell Lung Cancer Competitors

Name
Respiratory COPD Exacerbation
BAP-65 and DECAF Score
ATS Journals App
Synergy Community
ChemoSafe
Assessing chemotherapy safety
Neuro-Oncology Trials App
Non-Small-Cell Lung Cancer
OMF - Orthodox Mutual Fund
WorldLab 2022
June 26-30 Coex, Seoul, Korea
Colonic Pathology
Hopkins Atlas of Pathology
ALTAI Oncology
Protocols, Staging, and More

Non-Small Cell Lung Cancer Installs

Last 30 days

Non-Small Cell Lung Cancer Revenue

Last 30 days

Non-Small Cell Lung Cancer Revenue and Downloads

Gain valuable insights into Non-Small Cell Lung Cancer performance with our analytics.
Sign up now to access downloads, revenue, and more.